HoYAG vs TFL in miniPCNL With ClearPetra
Recruiting now · Not applicable
Conditions studied: Nephrolithiasis, Kidney Stone
In brief
Mini percutaneous nephrolithotripsy is the treatment of choice for kidney stones over 2cm. This procedure commonly uses laser energy for breaking the stones, and among possible laser platforms, Hoyag and thulium fiber laser are FDA approved. Recently, this procedure has also included the use of vacuum assisted renal access sheaths, which allows suction to be employed together with the breaking of stones. This study intends to compare outcomes when using either laser platforms with suction sheaths in participants undergoing mini percutaneous nephrolithotripsy for the treatment of kidney stones.
Key facts
- Study ID
- NCT07087977
- Run by
- University of Kansas Medical Center
- People needed
- 150
- Starts
- 2025-08-22
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-05-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males or females over 18 years of age
- Patients with kidney stones, with stone burden larger than 15 mm.
- Patients undergoing new percutaneous access with primary, supine, unilateral mini-PCNL.
You may not qualify if…
- Simultaneous use of more than 1 laser platform or other form of fragmentation (e.g., ultrasonic).
- Patients undergoing simultaneous treatment of contralateral kidney stones during the same procedure.
- Patients undergoing simultaneous treatment of ureteral stones during the same procedure.
- Pregnant patients.
- Presence of genitourinary anatomical abnormalities.
- Uncorrected coagulopathy.
- External urinary catheters.
- Immunosuppressed patients.
- Non-elective procedures.
Where it is running
- University of Kansas Medical Center — Kansas City, Kansas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.